{"brief_title": "Study to Compare Initial Dosing Parameters of Zemplar in Stage V Chronic Kidney Disease Subjects on Hemodialysis", "brief_summary": "To show non-inferiority in the incidence rates of elevated calcium-phosphorus product between two treatment groups: 1) a group having an initial dose based on baseline PTH (baseline iPTH/80) and 2) a group having a starting dose based on body weight (0.04 mcg/kg).", "condition": "Kidney Failure, Chronic", "intervention_type": "Drug", "intervention_name": "Zemplar", "criteria": "Inclusion Criteria: - Stage V Chronic Kidney Disease - Patients on Hemodialysis requiring treatment for secondary hyperparathyroidism with vitamin D therapy", "gender": "All", "minimum_age": "20 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00091481.xml"}